Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V W Steinijans

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1990
Pharmacokinetic characterization of controlled-release formulationsV W Steinijans
Journal of Biopharmaceutical Statistics|May 1, 1996
Directional decision for a two-tailed alternativeD Hauschke, V W Steinijans
Journal of Biopharmaceutical Statistics|March 1, 1997
Individual bioequivalence--a European perspectiveV W Steinijans, D Hauschke
European Journal of Clinical Pharmacology|January 1, 1985
Generalization of distribution--free confidence intervals for bioavailability ratiosV W Steinijans, E Diletti
Chronobiology International|January 1, 1987
Therapeutic advantage of unequal dosing of theophylline in patients with nocturnal asthmaP Dorow, V W Steinijans
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1990
Update on the statistical analysis of bioequivalence studiesV W Steinijans, D Hauschke
Statistics in Medicine|October 18, 2000
The U.S. draft guidance regarding population and individual bioequivalence approaches: comments by a research-based pharmaceutical companyD Hauschke, V W Steinijans
European Journal of Clinical Pharmacology|January 1, 1983
Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervalsV W Steinijans, E Diletti
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
Update on the statistical analysis of bioequivalence studiesV W Steinijans, D Hauschke
Controlled Clinical Trials|August 1, 1996
A note on conventional null hypothesis testing in active control equivalence studiesD Hauschke, V W Steinijans
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1990
Pharmacokinetic characterization of controlled-release formulationsV W Steinijans
Journal of Biopharmaceutical Statistics|May 1, 1996
Directional decision for a two-tailed alternativeD Hauschke, V W Steinijans
Journal of Biopharmaceutical Statistics|March 1, 1997
Individual bioequivalence--a European perspectiveV W Steinijans, D Hauschke
European Journal of Clinical Pharmacology|January 1, 1985
Generalization of distribution--free confidence intervals for bioavailability ratiosV W Steinijans, E Diletti
Chronobiology International|January 1, 1987
Therapeutic advantage of unequal dosing of theophylline in patients with nocturnal asthmaP Dorow, V W Steinijans
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1990
Update on the statistical analysis of bioequivalence studiesV W Steinijans, D Hauschke
Statistics in Medicine|October 18, 2000
The U.S. draft guidance regarding population and individual bioequivalence approaches: comments by a research-based pharmaceutical companyD Hauschke, V W Steinijans
European Journal of Clinical Pharmacology|January 1, 1983
Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervalsV W Steinijans, E Diletti
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
Update on the statistical analysis of bioequivalence studiesV W Steinijans, D Hauschke
Controlled Clinical Trials|August 1, 1996
A note on conventional null hypothesis testing in active control equivalence studiesD Hauschke, V W Steinijans
Pageof 11